Mammalian Polyclonal IgG Antibody Market Analysis and Demand 2018 – 2028 : F. Hoffman-La Roche, Merck KGaA
Sizeable investments made by biotech companies in emerging and developed markets has also offered a big fillip to the demand for mammalian polyclonal IgG antibodies.
View full press release